Cameron Turtle's Insider Trades & SAST Disclosures
Cameron Turtle's most recent trade in Spyre Therapeutics Inc. was a trade of 370,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Cameron Turtle.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Spyre Therapeutics Inc. | Cameron Turtle | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 370,000 | 370,000 | - | - | Stock Option (Right to Buy) | |
| Spyre Therapeutics Inc. | Turtle Cameron | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 9.82 per share. | 15 Feb 2024 | 400 | 746,907 (2%) | 0% | 9.8 | 3,928 | Common Stock |
| Aeglea BioTherapeutics Inc | Cameron Turtle | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 277,750 | 277,750 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 69.34 per share. | 28 Dec 2020 | 10,937 | 21,131 (0%) | 0% | 69.3 | 758,329 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 69.94 per share. | 28 Dec 2020 | 8,563 | 12,568 (0%) | 0% | 69.9 | 598,855 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 28 Dec 2020 | 7,500 | 20,068 (0%) | 0% | 17 | 127,500 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2020 | 7,500 | 255,500 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2020 | 6,000 | 56,042 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2020 | 6,000 | 31,766 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.16 per share. | 28 Dec 2020 | 6,000 | 32,068 (0%) | 0% | 0.2 | 960 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 28 Dec 2020 | 6,000 | 26,068 (0%) | 0% | 0.3 | 2,040 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 47.00 per share. | 24 Nov 2020 | 4,258 | 12,568 (0%) | 0% | 47.0 | 200,137 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2020 | 4,258 | 263,742 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 24 Nov 2020 | 4,258 | 16,826 (0%) | 0% | 17 | 72,386 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2020 | 742 | 263,000 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 47.23 per share. | 24 Nov 2020 | 742 | 12,568 (0%) | 0% | 47.2 | 35,044 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 24 Nov 2020 | 742 | 13,310 (0%) | 0% | 17 | 12,614 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 42.05 per share. | 05 Nov 2020 | 2,500 | 12,568 (0%) | 0% | 42.1 | 105,125 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2020 | 2,500 | 268,000 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 05 Nov 2020 | 2,500 | 15,068 (0%) | 0% | 17 | 42,500 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 37.59 per share. | 30 Sep 2020 | 12,442 | 14,626 (0%) | 0% | 37.6 | 467,751 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2020 | 6,000 | 37,766 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2020 | 6,000 | 62,042 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 30 Sep 2020 | 6,000 | 27,068 (0%) | 0% | 0.3 | 2,040 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.16 per share. | 30 Sep 2020 | 6,000 | 21,068 (0%) | 0% | 0.2 | 960 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2020 | 2,500 | 270,500 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 30 Sep 2020 | 2,500 | 15,068 (0%) | 0% | 17 | 42,500 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 38.24 per share. | 30 Sep 2020 | 2,058 | 12,568 (0%) | 0% | 38.2 | 78,707 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 18 Sep 2020 | 2,500 | 15,068 (0%) | 0% | 17 | 42,500 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2020 | 2,500 | 273,000 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 42.01 per share. | 18 Sep 2020 | 2,500 | 12,568 (0%) | 0% | 42.0 | 105,024 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 37.06 per share. | 15 Sep 2020 | 2,500 | 12,568 (0%) | 0% | 37.1 | 92,652 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2020 | 2,500 | 275,500 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 15 Sep 2020 | 2,500 | 15,068 (0%) | 0% | 17 | 42,500 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 35.02 per share. | 11 Sep 2020 | 2,000 | 12,568 (0%) | 0% | 35.0 | 70,047 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2020 | 2,000 | 43,766 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 11 Sep 2020 | 2,000 | 14,568 (0%) | 0% | 0.3 | 680 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2020 | 2,745 | 12,568 (0%) | 0% | 0 | Common Stock | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 32.65 per share. | 30 Jun 2020 | 9,700 | 10,123 (0%) | 0% | 32.6 | 316,671 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 6,000 | 68,042 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.16 per share. | 30 Jun 2020 | 6,000 | 15,823 (0%) | 0% | 0.2 | 960 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 30 Jun 2020 | 4,000 | 19,823 (0%) | 0% | 0.3 | 1,360 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 4,000 | 45,766 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 33.17 per share. | 30 Jun 2020 | 300 | 9,823 (0%) | 0% | 33.2 | 9,952 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 74,042 | 74,042 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 49,766 | 49,766 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2020 | 1,082 | 1,082 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 32.01 per share. | 27 Apr 2020 | 2,000 | 9,823 (0%) | 0% | 32.0 | 64,028 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 27 Apr 2020 | 2,000 | 11,823 (0%) | 0% | 17 | 34,000 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2020 | 2,000 | 278,000 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2020 | 8,000 | 280,000 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Sale of securities on an exchange or to another person at price $ 27.04 per share. | 08 Apr 2020 | 8,000 | 9,823 (0%) | 0% | 27.0 | 216,358 | Common Stock |
| BridgeBio Pharma Inc | Cameron Turtle | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 08 Apr 2020 | 8,000 | 17,823 (0%) | 0% | 17 | 136,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges